Log In
person
Enzo Biochem Inc.
ENZ
summarize
5 total product lines
calendar_month
Revenue as of 07/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Clinical Laboratory Services |
Medical Diagnostic Services; Private Insurance
These companies operate diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
55.98M | 52.28% |
| Clinical Laboratory Services |
Diversified Medical Diagnostic Services; Government Insurance
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
10.39M | 9.70% |
| Clinical Laboratory Services |
Diversified Medical Diagnostic Services; Self Paid
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
8.06M | 7.53% |
| Life Sciences Products |
Diversified Equipment for Drug Manufacturers
These companies manufacture equipment for pharmaceutical and biotech manufacturers and sell directly to their customers.
|
32.64M | 30.49% |
| Therapeutics |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Clinical Laboratory Services
Medical Diagnostic Services; Private Insurance
|
55.98M | 52.28% |
| keyboard_arrow_right |
These companies operate diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||
| keyboard_arrow_down |
Clinical Laboratory Services
Diversified Medical Diagnostic Services; Government Insurance
|
10.39M | 9.70% |
| keyboard_arrow_right |
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
||
| keyboard_arrow_down |
Clinical Laboratory Services
Diversified Medical Diagnostic Services; Self Paid
|
8.06M | 7.53% |
| keyboard_arrow_right |
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||
| keyboard_arrow_down |
Life Sciences Products
Diversified Equipment for Drug Manufacturers
|
32.64M | 30.49% |
| keyboard_arrow_right |
These companies manufacture equipment for pharmaceutical and biotech manufacturers and sell directly to their customers.
|
||
| keyboard_arrow_down |
Therapeutics
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||